Aerobic exercise prescription in patients with chronic heart failure: a review in the beta-blocker era

被引：3
|
作者：
Carvalho, Vitor Oliveira [1 ]
机构：
[1] USP InCor HC FMUSP, Unidade Cirurgia Cardiaca Pediat, Inst Coracao, Hosp Clin,Fac Med, BR-05403900 Sao Paulo, Brazil
来源：
JOURNAL OF CARDIOVASCULAR MEDICINE | 2012年 / 13卷 / 09期
关键词：
beta-blockers; carvedilol; exercise; heart failure; rehabilitation; OXYGEN-UPTAKE; RATE RESERVE; CARVEDILOL;
D O I：
10.2459/JCM.0b013e328356a3b2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aerobic exercise training is a well-established nonpharmacological tool in patients with clinically stable chronic heart failure. In recent years, beta-blocker therapy has become a primary pharmacologic intervention in patients with chronic heart failure. Despite the undeniable improvements in patients, the beta-blocker era has aroused uncertainties about aerobic exercise intensity prescription. It is well known that aerobic exercise prescription is performed by a percentage of the patient's heart rate reserve and the use of beta-blockers could interfere in this method. For this reason, the aim of this review is to provide an update about aerobic exercise prescription in patients with chronic heart failure who are using beta-blockers.
引用
收藏
页码：570 / 574
页数：5
相关论文
共 50 条
  • [41] Beta-blocker therapy in chronic heart failure: How do we treat patients with bradycardia?
    Kenta, I
    Tsuyoshi, S
    Hiroki, O
    Jun, N
    Yutaka, K
    Jun, W
    Kunio, S
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (05) : S185 - S185
  • [42] Effects of beta-blocker therapy on clinical outcomes in Japanese patients with chronic heart failure.
    Kawana, M
    Matsuda, N
    Kasanuki, H
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (11) : A41 - A41
  • [43] Disparity In Beta Blocker Prescription In Heart Failure
    Fabiano Filho, Ronaldo Correa
    Ibrahim, Joseph
    Thomas, Floyd
    Saba, Samir
    Hickey, Gavin
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 295 - 295
  • [44] Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
    Juan Martínez-Milla
    Marcelino Cortés García
    Julia Anna Palfy
    Mikel Taibo Urquía
    Marta López Castillo
    Ana Devesa Arbiol
    Ana Lucía Rivero Monteagudo
    María Luisa Martín Mariscal
    Inés Jiménez-Varas
    Sem Briongos Figuero
    Juan Antonio Franco-Pelaéz
    José Tu?ón
    Journal of Geriatric Cardiology, 2021, 18 (01) : 20 - 29
  • [45] The use of ratings of perceived exertion for exercise prescription in patients receiving beta-blocker therapy
    Eston, R
    Connolly, D
    SPORTS MEDICINE, 1996, 21 (03) : 176 - 190
  • [46] Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy
    Pascual-Figal, Domingo A.
    Penafiel, Pablo
    Nicolas, Francisco
    de la Morena, Gonzalo
    Ansaldo, Pilar
    Redondo, Belen
    Sanchez Mas, Jesus
    Valdes, Mariano
    REVISTA ESPANOLA DE CARDIOLOGIA, 2008, 61 (03): : 260 - 268
  • [47] Assessment of beta-blocker therapy in heart failure - How to manage patients?
    Swedberg, K
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (11) : A39 - A39
  • [48] Effect of beta-blocker in plasma norepinephrine levels in patients with heart failure
    Neto, JAF
    Grupi, C
    Mady, C
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S51 - S51
  • [49] What is the Determinant for Beta-Blocker use in Japanese Heart Failure Patients?
    Miura, Masanobu
    Shiba, Nobuyuki
    Nochioka, Kotaro
    Kono, Haruka
    Shimokawa, Hiroaki
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (09) : S163 - S164
  • [50] Economic impact of beta-blocker therapy in patients with congestive heart failure
    Cowper, PA
    Delong, ER
    Whellan, DJ
    Lapointe, NA
    Califf, RM
    CIRCULATION, 2002, 106 (16) : E106 - E106
12345